Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P190002/S052

Saluda Medical Evoke SCS System

Saluda Medical Pty, Ltd. · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONP190002/S052

What did the FDA decide?

The FDA record P190002/S052 is a 30-Day Notice supplement to PMA P190002 for the Saluda Medical Evoke SCS System, filed under the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier. The reported statement describes approval of additional sterilization chambers at one of Saluda's contract manufacturers. It does not describe a change to the stimulator itself or to its labeled indications.

The S supplement number links this action to the original P190002 approval, but it is a manufacturing-process notice, not a new approval of the whole device. The record does not identify the contract manufacturer, the number or location of added chambers, the sterilization method, or any validation data. The stated purpose of adding sterilization capacity is not independent evidence of safety or clinical effectiveness; those determinations are not established by this entry.

Whether the added chambers alter sterilization parameters or only capacity is absent from the supplied fields, so that distinction cannot be settled here.

FDA approval order statement

approval of additional sterilization chambers at one of Saludas contract manufacturers
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Neurology
Decision date
Oct 16, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P190002/S052
Regulatory pathway
PMA supplement
Product code
LGW
Decision code
OK30
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, spinal-cord, totally implanted for pain relief.

Product code
LGW
FDA device class
3

For the original device and its historical approval scope, see PMA P190002. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P190002 · Original PMA

    Saluda Medical Evoke SCS System

  2. P190002/S052 received

    Application receipt date recorded by FDA.

  3. P190002/S051 · Related supplement

    Saluda Medical Evoke SCS System

  4. P190002/S052 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P190002. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P190002

Product / regulatory recordCompanyPathwayDecision dateSource
Saluda Medical Pty, Ltd.PMA approvalFeb 28, 2022FDA
Saluda Medical Pty, Ltd.PMA supplementOct 15, 2026FDA

Explore the linked device profile

Other records with product code LGW

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Saluda Medical Pty, Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Level 1, 407 Pacific Hwy., Atarmon, NSW 2064

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records